1 of 1
Story summary
- China’s pharmaceutical industry is projected to grow 50% in revenue from 2024 to 2030, according to UBS.
- By 2030, revenue could exceed US$2.1 trillion.
- UBS projects revenue could reach US$3.2 trillion annually by 2050.
- The growth is driven by an ageing population and rising per-capita medical spending.
- Innovative drugs are set to grow 20% annually from 2026 to 2030.
